BioCentury
ARTICLE | Clinical News

Ceprate SC: Started two clinical trials equivalent of Phase I/II in France

September 27, 1993 7:00 AM UTC

CellPro Inc. (CPRO) Product: Ceprate SC stem cell concentration system Indication: Purify CD34+ stem cells from a patient's own blood to restore marrow and immune function after marrow ablation therap...